Entity Common Stock, Shares Outstanding of Arch Therapeutics, Inc. from 31 Mar 2012 to 19 Aug 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Arch Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Mar 2012 to 19 Aug 2024.
  • Arch Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 19 Aug 2024 was 4,444,364.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Arch Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 4,444,364 19 Aug 2024 10-Q 19 Aug 2024 2024 Q3
Q1 2024 4,444,363 01 May 2024 10-Q 09 May 2024 2024 Q2
Q4 2023 4,742,363 -245,194,007 -98% 14 Feb 2024 10-K/A 01 Mar 2024 2023 FY
Q2 2023 3,094,370 -246,842,000 -99% 11 Aug 2023 10-Q 11 Aug 2023 2023 Q3
Q4 2022 249,936,370 +12,766,600 +5.4% 28 Dec 2022 10-K 28 Dec 2022 2022 FY
Q2 2022 249,936,370 +13,216,600 +5.6% 11 Aug 2022 10-Q 11 Aug 2022 2022 Q3
Q1 2022 237,069,770 +350,000 +0.15% 13 May 2022 10-Q 13 May 2022 2022 Q2
Q4 2021 237,169,770 +44,125,004 +23% 16 Dec 2021 10-K/A 29 Dec 2021 2021 FY
Q2 2021 236,719,770 +43,675,004 +23% 12 Aug 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 236,719,770 +48,856,823 +26% 05 May 2021 10-Q 06 May 2021 2021 Q2
Q4 2020 193,044,766 +5,181,819 +2.8% 10 Dec 2020 10-K 11 Dec 2020 2020 FY
Q2 2020 193,044,766 +19,467,533 +11% 22 Jul 2020 10-Q 23 Jul 2020 2020 Q3
Q1 2020 187,862,947 +14,285,714 +8.2% 04 May 2020 10-Q 05 May 2020 2020 Q2
Q4 2019 187,862,947 +23,421,161 +14% 29 Jan 2020 10-Q 30 Jan 2020 2020 Q1
Q2 2019 173,577,233 +9,280,220 +5.6% 31 Jul 2019 10-Q 01 Aug 2019 2019 Q3
Q1 2019 173,577,233 +19,525,220 +13% 14 May 2019 10-Q 14 May 2019 2019 Q2
Q4 2018 164,441,786 +10,389,773 +6.7% 17 Dec 2018 10-K 18 Dec 2018 2018 FY
Q2 2018 164,297,013 +13,527,971 +9% 01 Aug 2018 10-Q 02 Aug 2018 2018 Q3
Q1 2018 154,052,013 +3,282,971 +2.2% 25 Apr 2018 10-Q 26 Apr 2018 2018 Q2
Q4 2017 154,052,013 +16,169,938 +12% 31 Jan 2018 10-Q 01 Feb 2018 2018 Q1
Q3 2017 153,935,130 14 Nov 2017 10-K 15 Nov 2017 2017 FY
Q2 2017 150,769,042 +16,561,694 +12% 26 Jul 2017 10-Q 27 Jul 2017 2017 Q3
Q1 2017 150,769,042 +33,941,794 +29% 01 May 2017 10-Q 02 May 2017 2017 Q2
Q4 2016 137,882,075 +29,002,523 +27% 02 Dec 2016 10-K 05 Dec 2016 2016 FY
Q2 2016 134,207,348 +33,580,107 +33% 27 Jul 2016 10-Q 28 Jul 2016 2016 Q3
Q1 2016 116,827,248 +40,750,761 +54% 27 Apr 2016 10-Q 28 Apr 2016 2016 Q2
Q4 2015 108,879,552 +32,803,065 +43% 10 Dec 2015 10-K 11 Dec 2015 2015 FY
Q2 2015 100,627,241 +28,550,754 +40% 05 Aug 2015 10-Q 07 Aug 2015 2015 Q3
Q1 2015 76,076,487 +4,000,000 +5.6% 07 May 2015 10-Q 07 May 2015 2015 Q2
Q4 2014 76,076,487 +15,931,250 +26% 10 Dec 2014 10-K 12 Dec 2014 2014 FY
Q2 2014 72,076,487 +12,931,250 +22% 05 Aug 2014 10-Q 06 Aug 2014 2014 Q3
Q1 2014 72,076,487 +68,116,487 +1720% 01 May 2014 10-K/A 01 May 2014 2013 FY
Q4 2013 60,145,237 +54,115,237 +897% 26 Dec 2013 10-K 27 Dec 2013 2013 FY
Q2 2013 59,145,237 +53,115,237 +881% 13 Aug 2013 10-Q 14 Aug 2013 2013 Q3
Q1 2013 3,960,000 -40,000 -1% 15 May 2013 10-Q 20 May 2013 2013 Q2
Q4 2012 6,030,000 31 Dec 2012 10-Q 14 Feb 2013 2013 Q1
Q3 2012 6,030,000 30 Sep 2012 10-K 31 Dec 2012 2012 FY
Q2 2012 6,030,000 30 Jun 2012 10-Q 14 Aug 2012 2012 Q3
Q1 2012 4,000,000 31 Mar 2012 10-Q 03 May 2012 2012 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.